Internal Medicine, Gastroenterology · Edmonds, WA
NPI
1174544712
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
21600 Hwy 99, Suite 260
Edmonds, WA, 98026
Phone (425) 774-2650
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
507 services
Medicare patients, 2024
276
Average age 75
Drug cost, 2024
$568K
2,485 prescriptions
Company payments, 2025
$2,036
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason I Schneier was code 99214 (office e&m - established), 129 times for 107 patients. In total Jason I Schneier billed 507 services in 26 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 129 | 107 | $87.08 | $11K |
| 99213 Office E&M - Established | Office | 106 | 86 | $68.13 | $7,222 |
| 43239 Upper GI Endoscopy | Facility | 44 | 42 | $66.50 | $2,926 |
| 45380 Lower GI Endoscopy - Other | Facility | 35 | 35 | $103.86 | $3,635 |
| 99202 Office E&M - New | Office | 34 | 34 | $42.95 | $1,460 |
| 45385 Colonoscopy - Lesion Removal | Facility | 33 | 33 | $205.93 | $6,796 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 24 | 24 | $170.11 | $4,083 |
| 99204 Office E&M - New | Office | 20 | 20 | $98.34 | $1,967 |
| 99203 Office E&M - New | Office | 16 | 16 | $88.37 | $1,414 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 12 | 12 | $178.17 | $2,138 |
| 43248 Upper GI Endoscopy | Facility | 11 | 11 | $88.73 | $976 |
| 43235 Upper GI Endoscopy | Facility | 11 | 11 | $66.08 | $727 |
By year: 2022 $70K for 678 services; 2023 $53K for 542 services; 2024 $49K for 507 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jason I Schneier prescribed most often to Medicare patients was Omeprazole, with 249 prescriptions and refills. In total Jason I Schneier wrote 2,485 Medicare prescriptions that cost $568K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 249 | 504 | 78 | $3,487 |
| Famotidine Generic | 204 | 354 | 47 | $2,471 |
| Misoprostol Generic | 172 | 246 | 46 | $5,389 |
| Budesonide Dr Budesonide | 71 | 104 | 22 | $4,178 |
| Colestipol Hcl Generic | 67 | 135 | 29 | $4,326 |
| Pentoxifylline Generic | 63 | 97 | 13 | $1,206 |
| Sucralfate Generic | 60 | 102 | 18 | $1,223 |
| Pantoprazole Sodium Generic | 60 | 164 | 25 | $611 |
| Metoclopramide Hcl Generic | 57 | 84 | 25 | $223 |
| Prednisone Generic | 55 | 71 | 18 | $248 |
| Mesalamine Generic | 54 | 112 | 16 | $21K |
| Ursodiol Generic | 49 | 91 | 11 | $6,478 |
| Gabapentin Generic | 40 | 64 | 12 | $477 |
| Linzess Linaclotide | 39 | 67 | 12 | $35K |
| Loperamide Loperamide Hcl | 38 | 92 | 16 | $1,377 |
Brand drugs: - claims; generic drugs: 2,134 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason I Schneier $2,036 ($2,036 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $382.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $382 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $354 |
| Janssen Biotech, Inc. JNJ | 6 | $223 |
| Phathom Pharmaceuticals, Inc. PHAT | 9 | $199 |
| Pfizer Inc. PFE | 10 | $177 |
| Aimmune Therapeutics, Inc. | 8 | $171 |
| Madrigal Pharmaceuticals MDGL | 6 | $161 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $72.47 |
| Celltrion USA Inc. 068270.KS | 3 | $66.39 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $49.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.